Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Guideline on medicinal products for the treatment of insomnia
[PDF, 161.14 KB]
About this guideline
Overseas effective date: September 2011
Replaces: pp. 359 - 370 of Rules 1998 (3C) - 3CC27a. Clinical Investigation of Hypnotic Medicinal Products (adopted by TGA July 1994)
Categories: Clinical efficacy and safety | Nervous system
TGA annotations: nil
- Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
- All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.
For more information see International scientific guidelines adopted in Australia.